The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 09, 2019

Filed:

Apr. 04, 2018
Applicant:

Gilead Sciences, Inc., Foster City, CA (US);

Inventors:

Peter A. Blomgren, Issaquah, WA (US);

Kevin S. Currie, North Bend, WA (US);

Jeffrey E. Kropf, Issaquah, WA (US);

Seung H. Lee, Branford, CT (US);

Jennifer R. Lo, Branford, CT (US);

Scott A. Mitchell, East Haven, CT (US);

Aaron C. Schmitt, Hamden, CT (US);

Sundaramoorthi Swaminathan, Burlingame, CA (US);

Jin-Ming Xiong, Guilford, CT (US);

Jianjun Xu, Seattle, WA (US);

Zhongdong Zhao, Guilford, CT (US);

Assignee:

Gilead Sciences, Inc., Foster City, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4985 (2006.01); C07D 487/04 (2006.01); A61K 9/00 (2006.01); A61K 31/5377 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4985 (2013.01); A61K 9/0053 (2013.01); A61K 31/5377 (2013.01); C07D 487/04 (2013.01);
Abstract

The present disclosure relates to compounds that are Syk inhibitors and to their use in the treatment of various disease states, including cancer and inflammatory conditions. In particular embodiments, the structure of the compounds is given by Formula I: wherein R, R, R, and Rare as described herein. The present disclosure further provides pharmaceutical compositions that include a compound of Formula I, or pharmaceutically acceptable salts or co-crystals thereof, and methods of using these compounds and compositions to treat conditions mediated by Syk.


Find Patent Forward Citations

Loading…